Background Endovascular treatment of cerebral aneurysms in the posterior circulation poses a challenge because of the higher rate of wide-necked aneurysms and presentation with rupture. In this study, we compare the baseline characteristics and outcomes of patients with posterior circulation aneurysms treated with novel second-generation coils in the SMART registry.
Methods SMART is a phase 4, multicenter, prospective, registry that enrolled patients with anterior and posterior circulation cerebral aneurysms (both ruptured and unruptured) who underwent endovascular treatment using Penumbra SMART™ Coils. Collected data included baseline clinical and angiographic characteristics at presentation. Primary and secondary end points were immediate angiographic occlusion, periprocedural complications, recanalization and retreatment rates and mortality at 1-year follow up. We compared the above variables between anterior and posterior circulation aneurysms.
Results Of a total of 906 patients treated in the SMART registry, 173 (19.1%) had posterior circulation aneurysms. In comparison to patients with anterior circulation aneurysms, patients with aneurysms in the posterior circulation were older (mean age 61.7 vs. 59.3 years, P 0.017) and more likely to present with rupture (38.7% vs. 30.3%, P 0.032). Posterior circulation aneurysms were more likely to be wide-necked (defined as an aneurysm with a dome-to-neck ratio less than 2.0 and/or a neck length of 4 mm or more). No significant difference was found in the rate of successful embolization at initial procedure (Raymond Class I), serious device-related adverse effects within 24 hours, one-year recanalization and one-year retreatment between both groups (table 1).
Conclusions Despite being associated with higher rates of rupture and wide-necked geometry, patients with posterior circulation aneurysms experienced immediate and one-year angiographic occlusion rates that were not significantly different from anterior circulation aneurysms. Device-related peri-procedural complications were also not significantly higher than the latter.
Disclosures E. Almallouhi: None. M. Sattur: None. M. Anadani: None. S. Al kasab: None. A. Spiotta: 2; C; Penumbra, Cerenovus, Minnetronix.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.